3-amino-4-(benzofuran-2-yl)-5,6,7,8,9,10-hexahydrocycloocta[b]thieno[3,2-e]pyridine-2-carboxamide

ID: ALA1091074

PubChem CID: 46884244

Max Phase: Preclinical

Molecular Formula: C22H21N3O2S

Molecular Weight: 391.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1sc2nc3c(c(-c4cc5ccccc5o4)c2c1N)CCCCCC3

Standard InChI:  InChI=1S/C22H21N3O2S/c23-19-18-17(16-11-12-7-5-6-10-15(12)27-16)13-8-3-1-2-4-9-14(13)25-22(18)28-20(19)21(24)26/h5-7,10-11H,1-4,8-9,23H2,(H2,24,26)

Standard InChI Key:  SDTHLSZHADBMSE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   15.3577  -23.3908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3578  -22.5633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9425  -21.9786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9426  -23.9715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7700  -23.9715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7700  -21.9785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3506  -22.5633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3474  -23.3898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0605  -23.8040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0627  -22.1527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7763  -22.5631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7737  -23.3950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5641  -23.6545    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   20.0552  -22.9830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5682  -22.3086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8256  -21.5248    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8802  -22.9855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2905  -23.7012    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2948  -22.2723    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0622  -21.3277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7241  -20.8425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3893  -20.8433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6437  -20.0585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4672  -20.0585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8772  -19.3465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4648  -18.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6381  -18.6379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2318  -19.3505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  1  2  1  0
 15 16  1  0
  7  8  2  0
 14 17  1  0
  2  3  1  0
 17 18  2  0
  8  9  1  0
 17 19  1  0
  9 12  2  0
 10 20  1  0
 20 21  2  0
  1  4  1  0
 11 10  2  0
 21 24  1  0
 23 22  1  0
 22 20  1  0
 10  7  1  0
 11 12  1  0
 23 24  2  0
  4  5  1  0
 24 25  1  0
  5  8  1  0
 25 26  2  0
  7  6  1  0
 26 27  1  0
  6  3  1  0
 27 28  2  0
 28 23  1  0
M  END

Associated Targets(Human)

EEF2K Tchem Serine/threonine-protein kinase EEF2K (1246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 391.50Molecular Weight (Monoisotopic): 391.1354AlogP: 5.05#Rotatable Bonds: 2
Polar Surface Area: 95.14Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.74CX LogD: 4.74
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -0.97

References

1. Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal V, Adam Willardsen J..  (2010)  Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues.,  20  (7): [PMID:20189382] [10.1016/j.bmcl.2010.02.005]

Source